about
Metabolic factors and chronic hepatitis C: a complex interplayPathophysiology of portal hypertensionApplication of a nitric oxide sensor in biomedicinePhosphodiesterase-5 inhibitors have distinct effects on the hemodynamics of the liverRetrospective Study to Compare Selective Decongestive Devascularization and Gastrosplenic Shunt versus Splenectomy with Pericardial Devascularization for the Treatment of Patients with Esophagogastric Varices Due to Cirrhotic Portal HypertensionImportance of hepatitis C virus-associated insulin resistance: therapeutic strategies for insulin sensitizationBone marrow-derived stromal cell therapy in cirrhosis: clinical evidence, cellular mechanisms, and implications for the treatment of hepatocellular carcinoma.Aquaporin-1 promotes angiogenesis, fibrosis, and portal hypertension through mechanisms dependent on osmotically sensitive microRNAsImmortalized liver endothelial cells: a cell culture model for studies of motility and angiogenesis.Clinical pharmacology of portal hypertension.Management of cirrhotic ascitesPrevention and management of gastroesophageal varices in cirrhosis.The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF Test.Plasma betatrophin levels in patients with liver cirrhosisCell signals influencing hepatic fibrosisInflammation: a way to understanding the evolution of portal hypertension.High Flow-Mediated Vasodilatation Predicts Pulmonary Edema in Liver Transplant Patients.The mast cell integrates the splanchnic and systemic inflammatory response in portal hypertension.Cirrhosis is a risk factor for total hip arthroplasty for avascular necrosisLiver cell-derived microparticles activate hedgehog signaling and alter gene expression in hepatic endothelial cells.Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.Elevated nitric oxide and 3',5' cyclic guanosine monophosphate levels in patients with alcoholic cirrhosis.Relationship between angiotensin-(1-7) and angiotensin II correlates with hemodynamic changes in human liver cirrhosis.Autonomic dysfunction in cirrhosis and portal hypertension.Interaction between NO and COX pathways modulating hepatic endothelial cells from control and cirrhotic rats.Bedside sublingual video imaging of microcirculation in assessing bacterial infection in cirrhosis.Ascites: pathogenesis and therapeutic principles.Posterior reversible encephalopathy syndrome in alcoholic hepatitis: Hepatic encephalopathy a common themeNow there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis.Immunofluorescence identifies distinct subsets of endothelial cells in the human liverRegulation of hepatic blood flow: the hepatic arterial buffer response revisited.Endothelial dysfunction in the regulation of cirrhosis and portal hypertension.Coagulation in hepatobiliary disease.Current concepts on the role of nitric oxide in portal hypertension.Increased circulatory asymmetric dimethylarginine and multiple organ failure: bile duct ligation in rat as a model.Ascites and spontaneous bacterial peritonitis: recommendations from two United States centers.Cirrhosis and portal hypertension: The importance of risk stratification, the role of hepatic venous pressure gradient measurement.Tobacco Use is a Modifiable Risk Factor for Post-Transplant Biliary Complications.Emerging role of exosomes in liver physiology and pathology.Non-alcoholic fatty liver disease, to struggle with the strangle: Oxygen availability in fatty livers.
P2860
Q27011787-23079764-C097-4597-8A4F-483F4BBA6791Q27026406-036471C6-5371-4A04-929A-1F2E52EED516Q28081440-DA6F218B-8326-4EF4-AA31-5BB76C013779Q33504875-18FC55CE-AFE2-4234-BB2B-7A90CAECA7F0Q33803630-4604C232-4061-4C36-88F3-A41783A8566EQ33812148-F9E2BFA6-AD36-41C6-A592-C0CA4102FFEEQ33818431-380317EE-7C46-4529-823F-C73376BE8402Q34209321-769C48B3-A75E-4CFA-B9CD-8F0334C0702EQ34354070-06754DEE-9CA4-4F85-B5AF-D38706C64978Q34399357-2E36CBBB-74B3-4D8A-9F4F-21F1A3F4D1C6Q34475601-19DDEE54-9E8E-4934-814E-721978352118Q34638216-C3F76CEF-BE69-4C14-A393-007C9BDBD816Q35928746-962EA5C7-E3DE-4DDC-AB3D-280F67B2E2F8Q36105642-4DB69091-7BC6-4ECD-AC32-C64B935BDDECQ36220879-EAAE4D14-CBFF-4B48-B4E0-97BCA22C412DQ36391634-FCC34A51-79E8-419E-B90F-BE9A0F483574Q36721334-B78B1EBE-0FBA-4299-AE78-0B5773030544Q36950557-66FBB33B-5D3C-43EC-A9F7-627AA73626BDQ36987000-15D4BEF4-BDB6-4593-9DC5-CD5DF4318D63Q37047177-E4EE3089-9B2B-4976-95C9-849791F6B2A8Q37121662-FEB7D2A7-801D-43C5-9DBF-2258758C5FEBQ37174153-3B5B9973-5DA8-42BA-8906-39D4679EF842Q37203406-F8FEE20A-846B-46DC-9EC8-E78610873A70Q37210058-09114219-B1C7-43EB-BA4A-65E03F8DC739Q37296246-3377A3EE-873C-44F6-9476-FE3E52B949B9Q37424402-C145D5EA-A2A0-4743-BA76-B9DA2C13F8BAQ37500169-97D65DF0-72BA-4C05-A7D5-9E4B9FD83CBBQ37586277-A88595D6-5D7C-4BF7-AF8C-650685139012Q37676132-958CEC09-960B-4810-B4E3-B72476497D69Q37695203-24D6490E-EA98-431B-8721-625DC8D9D776Q37823542-9F265EAD-C603-45C5-A1E4-CEF18858187BQ37899947-D5C7C471-8958-4AFA-8E22-068CB89AB6D0Q37982415-7F1FAF89-C73A-4604-B738-47C7D6987B05Q38095931-59602FC6-DA74-4FBD-AE8A-94C698A3AEC0Q38194032-585A505C-7241-4F98-BA58-F4829162CFDFQ38254071-9BC49B81-0010-4A64-8BEF-BCA940E2A47CQ38417924-25EDF753-5D9D-4393-B876-4EE159582ADDQ38635550-1A7B2ABB-BDF8-4DD8-868E-0FD45B5E6058Q38931228-C54A6F0B-F1FE-4CBF-BE2B-5100A98A9121Q39408396-18208E72-9E80-4272-8D8C-287CF8A07827
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Vascular endothelial dysfunction in cirrhosis.
@ast
Vascular endothelial dysfunction in cirrhosis.
@en
type
label
Vascular endothelial dysfunction in cirrhosis.
@ast
Vascular endothelial dysfunction in cirrhosis.
@en
prefLabel
Vascular endothelial dysfunction in cirrhosis.
@ast
Vascular endothelial dysfunction in cirrhosis.
@en
P1476
Vascular endothelial dysfunction in cirrhosis.
@en
P2093
Roberto J Groszmann
Yasuko Iwakiri
P304
P356
10.1016/J.JHEP.2007.02.006
P577
2007-03-05T00:00:00Z